{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Drug Updates and Approvals: 2017 in Review

Purpose of Activity

To acquaint clinicians with several new primary care drugs approved by the FDA during the first half of 2017.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Identify indications and contraindications for each drug discussed.
  2. Discuss administration, adverse reactions, and monitoring requirements related to the medications.
Price: $17.95


  • ACPE 1.0 CEU

It is important to identify, resolve, and prevent medication-related problems among home care clients to minimize hospitalizations and emergency room visits. This article discusses a pharmacist-nurse collaborative model in the management of home care clients' medications.

Accreditation Statement:
Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Professions: Pharmacist
Test Code: NP1217-Pharm
Published: July 2018
Expires: 11/29/2021
Passing Score: 13/18 (72%)
Authors: Geoffrey Mospan, PharmD, BCPS; Cortney Mospan, PharmD, BCACP, BCGP; Shayna Vance; Alyssa Bradshaw; Kalyn Meosky; Kirklin Bowles
Categories: Drug Therapy